Ecovyst Inc. (ECVT) is a Wayne, Pennsylvania-based producer of virgin and regenerated sulfuric acid and sulfur dioxide derivatives, serving refining, mining, water treatment, and industrial customers primarily in North America. The stock traded at $9.65 shortly after the open, a decline of 6.58% from the previous session's close of $10.33. The direction was decisively negative. Markets attributed the move to the company's pre-market announcement that Chief Executive Officer Kurt J. Bitting had departed and that director David A. Bradley would serve as interim CEO.
The company disclosed that Bitting ceased serving as President and CEO and resigned from the board effective November 17, 2026, with Bradley, a director since 2022, appointed interim CEO the same day. The board shrank to seven members. Bitting will consult through February 5, 2027.
What unsettled investors was the timing. The change came roughly two weeks after a third-quarter report in which sales rose 50.6% to $308.6 million, adjusted EBITDA reached $61.2 million, and management raised full-year guidance for the third consecutive quarter. The filing characterized the separation as a termination without cause and stated it was not the result of any disagreement over operations, policies, or practices, but offered no strategic rationale. Severance terms include two years of base salary and target bonus. Bradley, a chemical-industry veteran who previously ran SI Group and Nexeo Solutions, will earn a $1.1 million base salary plus $2.0 million in restricted stock units.
The exit follows the August appointment of Laurie Bergman as chief financial officer, making this the second senior leadership transition in three months. For a roughly $1 billion market-cap company executing an integration of the Calabrian sulfur dioxide business acquired in June, back-to-back changes at the top of the organization introduce execution risk that investors have little information to price. The open-ended search for a permanent CEO adds a layer of uncertainty over capital allocation, including the plan to deploy up to $20 million on buybacks in the second half.
The selloff was tempered by an unchanged outlook. Ecovyst reiterated full-year 2026 sales of $1.05 billion to $1.07 billion, adjusted EBITDA of $208 million to $212 million, adjusted earnings of $0.63 to $0.77 per share, and adjusted free cash flow of $50 million to $60 million, along with fourth-quarter adjusted EBITDA of $54 million to $58 million. Shares recovered from an opening print near $9.35 and an intraday low of $9.33 to trade near $9.65, indicating that buyers stepped in once the reaffirmation was digested.
Trading volume in the opening hour ran close to the stock's typical pace of roughly 1.35 million shares a day rather than surging, suggesting the selling reflected sentiment adjustment rather than forced liquidation. The decline ran against a firmer broad tape, as index futures rose following robust semiconductor earnings, with Federal Reserve meeting minutes due later in the session. That divergence reinforces the company-specific nature of the move.
Technically, the session broke below the 50-day moving average near $10.18 and undercut the October 1 low of $9.56, a level that had framed the post-earnings range. The rebound back above that level leaves the stock still well beneath its 200-day moving average near $11.76 and roughly 36% below its 52-week high of $15.09, within a 52-week range of $8.11 to $15.09.
The scale runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. The score here is 48 out of 100.
The verified news was moderate in weight relative to a company of this size: an unplanned CEO departure with two-year severance, unexplained circumstances, and a reaffirmed outlook that limited fundamental damage. The price action was unusual. The 6.58% decline was roughly 4.3 times the stock's typical daily move of about 1.5%, and no session in the past 79 trading days produced a larger close-to-close swing, with the biggest at 5.72% in mid-September. A meaningful catalyst paired with a rare move, but not a transformative one, produces the score above.
Attention shifts to the board's search for a permanent chief executive and the terms of Bitting's separation, which could be detailed further in filings. Fourth-quarter results, expected in late February, will test whether cash conversion supports the $50 million to $60 million free cash flow target after year-to-date adjusted free cash flow of $32.4 million trailed the prior year. Management has flagged a heavier 2027 turnaround schedule of six sulfuric acid plant turnarounds, a fourth-quarter Tampa sulfur index decline to $615 per ton, and the risk of year-end destocking. Net leverage of 2.1 times and liquidity of $167 million leave less room for error. Analyst consensus remains constructive, though price targets have drifted lower, and the interim chief's capital allocation priorities will be closely watched.
Tickeron's Trending AI Robots page curates the strongest-performing automated strategies from a library of hundreds of AI trading bots spanning thousands of tickers. Rather than listing every model, it highlights only those bots delivering the best results under current market conditions. Bots differ widely by strategy logic, trading timeframe, performance metrics, and the symbols they trade, so the featured lineup shifts as conditions change. Reviewing the page is a practical way to see which automated approaches are working right now and how they might complement your own research.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ECVT broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 44 similar instances where the stock broke above the upper band. In 34 of the 44 cases the stock fell afterwards. This puts the odds of success at 77%.
The 10-day RSI Indicator for ECVT moved out of overbought territory on November 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 19 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECVT as a result. In 70 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for ECVT turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 61 similar instances when the indicator turned negative. In 44 of the 61 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
ECVT moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for ECVT crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +5.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECVT advanced for three days, in 201 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.956) is normal, around the industry mean (2.284). P/E Ratio (-19.792) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.820) is also within normal values, averaging (1.548). ECVT's Dividend Yield (1.220) is considerably higher than the industry average of (0.039). P/S Ratio (1.417) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. ECVT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of catalysts, specialty materials and chemicals
Industry ChemicalsSpecialty